126 results
Page 4 of 7
6-K
EX-99.1
lbc2td5uspezz
6 Feb 14
Teva Reports Fourth Quarter and Full Year 2013 Results
12:00am
6-K
EX-99.1
b8pbndme74ozo
29 Jan 14
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mL
12:00am
6-K
EX-99.1
wgz3b4w0
24 Jan 14
Live Filing
12:00am
6-K
EX-99.1
w798q126c
13 Jan 14
Live Filing
12:00am
6-K
EX-99.1
dq8sj23zf33
9 Jan 14
Teva Names Erez Vigodman as President and CEO
12:00am
6-K
EX-99.1
19jai0jkzr2y1w
3 Jan 14
Live Filing
12:00am
6-K
EX-99.1
zdvamdxl
17 Dec 13
Teva Settles Viagra® Patent Litigation with Pfizer
12:00am
6-K
EX-99.1
0y3ccnl
10 Dec 13
Live Filing
12:00am
6-K
EX-99.1
q0o1urmqps2
10 Dec 13
Teva Provides 2014 Non-GAAP Financial Outlook
12:00am
6-K
EX-99.1
3tqks8m854ks4 ol92
4 Dec 13
Teva and Takeda Announce Development and Distribution Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
12:00am
6-K
EX-99.1
4qj2l w241q1l
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
5b4xw00707wt
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
zlk04v4
27 Nov 13
Teva Announces Additional Regulatory Exclusivity for Treanda® (Bendamustine Hci) for Injection
12:00am
6-K
EX-99.1
svgszowg
25 Nov 13
Teva and Mylan Settle Copaxone® Patent Litigation In France, the Uk and the Netherlands
12:00am
6-K
EX-99.1
ni49jiwma
25 Nov 13
Live Filing
12:00am
6-K
EX-99.1
1s8scdd
19 Nov 13
Live Filing
12:00am
6-K
EX-99.1
hou411kodxfs t334hyy
18 Nov 13
Teva Announces Updates to Oncology Biologic Portfolio
12:00am